ANN PATRICK MEAGHER: Open Payments
NPI 1063072825 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,211 in 31 payments from 10 companies in 2025. Trend: 2023 $595 · 2024 $675 · 2025 $1,211
Food & beverage: $1,211
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 11 | $279 |
| Regeneron Healthcare Solutions, Inc. | 2 | $253 |
| Arcutis Biotherapeutics, Inc. | 5 | $244 |
| Organon LLC | 4 | $193 |
| GENZYME CORPORATION | 2 | $63 |
| Incyte Corporation | 3 | $55 |
| Boston Scientific Corporation | 1 | $47 |
| Novartis Pharmaceuticals Corporation | 1 | $31 |
| LEO Pharma Inc. | 1 | $31 |
| Janssen Biotech, Inc. | 1 | $14 |
Products named: DUPIXENT, Zoryve, NEMLUVIO, VTAMA, OPZELURA, WaveWriter Alpha Prime 16, ANZUPGO, TREMFYA.
Industry payments across GA — which companies pay providers there.
